LEVIN CAPITAL STRATEGIES, L.P. – Aerie Pharmaceuticals, Inc. Transaction History
LEVIN CAPITAL STRATEGIES, L.P. portfolio value:
$17.02M
portfolio value
LEVIN CAPITAL STRATEGIES, L.P. quarter portfolio value change:
+101.73%
quarter
Aerie Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -8.39% | -103.13K shares | 7.81M | $15.13 | 1.12M |
Q2 2022 | share | Decrease | -14.44% | -207.35K shares | -3.85M | $7.5 | 1.22M |
Q1 2022 | share | Increase | +75.67% | 618.49K shares | 7.32M | $9.1 | 1.43M |
Q4 2021 | call | Decrease | -100.00% | -32.5K shares | -371K | $7.17 | 0 |
Q4 2021 | share | Decrease | -40.49% | -556.16K shares | -9.92M | $7.17 | 817.37K |
Q3 2021 | call | Increase | 0.00% | 32.5K shares | 371K | $11.4 | 32.5K |
Q3 2021 | share | Increase | +1.73% | 23.35K shares | -5.95M | $11.4 | 1.37M |
Q2 2021 | share | Increase | +47.74% | 436.29K shares | 5.28M | $16.01 | 1.35M |
Q1 2021 | share | Increase | +22.86% | 170.03K shares | 6.28M | $17.87 | 913.88K |
Q4 2020 | share | Decrease | -44.78% | -603.13K shares | -5.80M | $13.51 | 743.85K |
Q3 2020 | share | Decrease | -22.90% | -400.11K shares | -9.93M | $11.77 | 1.34M |
Q2 2020 | share | Increase | +16.41% | 246.34K shares | 5.52M | $14.76 | 1.74M |
Q1 2020 | share | Decrease | -10.36% | -173.50K shares | -20.20M | $13.5 | 1.50M |
Q4 2019 | share | Increase | +40.62% | 483.65K shares | 17.58M | $24.17 | 1.67M |
Q3 2019 | share | Increase | +436.33% | 968.61K shares | 16.32M | $19.22 | 1.19M |
Q2 2019 | share | Increase | +4339.80% | 216.99K shares | 6.32M | $29.55 | 221.99K |
Q1 2019 | share | Increase | 0.00% | 5K shares | 237K | $47.5 | 5K |